首页 > 最新文献

Expert Review of Ophthalmology最新文献

英文 中文
Immunopathogenesis of ocular toxoplasmosis and implications for treatment 眼弓形虫病的免疫发病机制及对治疗的影响
IF 0.7 Pub Date : 2023-11-29 DOI: 10.1080/17469899.2023.2279178
J. Gomez Marin, Alejandra de la Torre, Mónica Vargas-Montes
{"title":"Immunopathogenesis of ocular toxoplasmosis and implications for treatment","authors":"J. Gomez Marin, Alejandra de la Torre, Mónica Vargas-Montes","doi":"10.1080/17469899.2023.2279178","DOIUrl":"https://doi.org/10.1080/17469899.2023.2279178","url":null,"abstract":"","PeriodicalId":39989,"journal":{"name":"Expert Review of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139211688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rod mediated dark adaptation, a functional test for early and intermediate AMD outcomes 视杆细胞介导的暗适应,对早期和中期老年黄斑变性结果的功能测试
IF 0.7 Pub Date : 2023-11-23 DOI: 10.1080/17469899.2023.2287178
Cynthia Owsley, Thomas A. Swain, Deepayan Kar, C. Curcio
{"title":"Rod mediated dark adaptation, a functional test for early and intermediate AMD outcomes","authors":"Cynthia Owsley, Thomas A. Swain, Deepayan Kar, C. Curcio","doi":"10.1080/17469899.2023.2287178","DOIUrl":"https://doi.org/10.1080/17469899.2023.2287178","url":null,"abstract":"","PeriodicalId":39989,"journal":{"name":"Expert Review of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139242824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting the complement system in geographic atrophy: mechanisms and therapeutics 针对地理萎缩中的补体系统:机制与疗法
IF 0.7 Pub Date : 2023-11-20 DOI: 10.1080/17469899.2023.2286607
Majid Khan, Olawale E. Akinyemi, Maliha Masud, Mathew J. Thomas, Nicholas Martin, A. Khanani
{"title":"Targeting the complement system in geographic atrophy: mechanisms and therapeutics","authors":"Majid Khan, Olawale E. Akinyemi, Maliha Masud, Mathew J. Thomas, Nicholas Martin, A. Khanani","doi":"10.1080/17469899.2023.2286607","DOIUrl":"https://doi.org/10.1080/17469899.2023.2286607","url":null,"abstract":"","PeriodicalId":39989,"journal":{"name":"Expert Review of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139258379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examining correlation between ocular microbiome and ocular diseases including keratitis 研究眼部微生物群与包括角膜炎在内的眼部疾病之间的相关性
IF 0.7 Pub Date : 2023-11-20 DOI: 10.1080/17469899.2023.2284313
S. Shivaji
{"title":"Examining correlation between ocular microbiome and ocular diseases including keratitis","authors":"S. Shivaji","doi":"10.1080/17469899.2023.2284313","DOIUrl":"https://doi.org/10.1080/17469899.2023.2284313","url":null,"abstract":"","PeriodicalId":39989,"journal":{"name":"Expert Review of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139255383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An update of recommendations for follow-up care following unsuccessful cataract surgery 白内障手术失败后后续护理建议的更新
IF 0.7 Pub Date : 2023-11-16 DOI: 10.1080/17469899.2023.2284881
Manpreet Kaur, Akshaya Balaji, J. Titiyal, Sridevi Nair
{"title":"An update of recommendations for follow-up care following unsuccessful cataract surgery","authors":"Manpreet Kaur, Akshaya Balaji, J. Titiyal, Sridevi Nair","doi":"10.1080/17469899.2023.2284881","DOIUrl":"https://doi.org/10.1080/17469899.2023.2284881","url":null,"abstract":"","PeriodicalId":39989,"journal":{"name":"Expert Review of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139267822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lower blepharoplasty; advanced techniques and adjunctive procedures 眼睑整容术;低先进的技术和辅助程序
Pub Date : 2023-11-12 DOI: 10.1080/17469899.2023.2281442
Nasser Karimi, Parya Abdolalizadeh, Hossein Ghahvehchian, Mansooreh Jamshidian Tehrani, Christopher J Compton, Jeremy D Clark, Nicole L West, Mohsen Bahmani Kashkouli
ABSTRACTIntroduction There are two main techniques of lower blepharoplasty: transcutaneous and transconjunctival approaches. Most patients seeking lower eyelid rejuvenation have concomitant involutional changes in the lower eyelid and midface, which would better be addressed concurrently with the lower blepharoplasty procedure to yield better aesthetic and functional outcomes.Areas covered This study aims to review common aging-related changes in the lower eyelid as well as important preoperative considerations, surgical techniques, and various modifications of lower blepharoplasty. A literature search was performed in the PubMed database of English-language journals without restriction on the publication date using selected keywords. The relevant articles were selected by reviewing the titles and abstracts.Expert opinion The lower eyelid and midface should be perceived as a continuum. Currently the fat preservation approach is the mainstream in lower blepharoplasty to prevent postoperative skeletonization of the eye. Fat transposition, via either pedicled fat flaps or free fat grafts, is used to efface tear trough deformity and the eyelid-cheek junction as a primary aim inaesthetic lower eyelid surgeries. Lower blepharoplasty can also be combined with adjuvant procedures to address festoon and droopy midface in selected individuals.KEYWORDS: Lower blepharoplastylower eyelidtear troughtransconjunctival blepharoplastytransconjunctival blepharoplastyorbital fat Article highlights The composite morphology of lower eyelid and mid-face aging is commonly designated as the double convexity deformity.The concept of lower blepharoplasty has shifted from a pure subtractive surgery to fat reposition, conservative skin excision and blending of the eyelid-cheek junction.Releasing the orbicularis retaining ligament is a crucial step in lower blepharoplasty, specifically for patients with an untoward infraorbital hollow.Although pedicled fat flap transposition can effectively efface the infraorbital hollow, this technique has some downsides.Recently it has been demonstrated that the aims of fat redistribution in lower blepharoplasty can be safely achievable by the minced fat graft technique.Most, if not all, cases of lower blepharoplasty would better be complemented with prophylactic canthal anchoring techniques to prevent lower eyelid malposition.Suborbicularis oculi fat elevation is an alternative to lower eyelid fat repositioning, particularly for subjects with negative vectors or hypoplastic malar prominences.Declaration of interestsJD Clark is a professional speaker for Horizon therapeutics. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.Reviewer disclosuresPeer reviewers on this manuscript have no relevant financial or other relationships to disclose.Additio
下睑成形术主要有两种方法:经皮和经结膜入路。大多数寻求下眼睑年轻化的患者都伴有下眼睑和中脸的交替变化,这最好与下眼睑成形术同时进行,以获得更好的美学和功能效果。本研究旨在回顾下眼睑常见的与衰老相关的变化,以及重要的术前注意事项、手术技术和下眼睑成形术的各种修改。在PubMed英文期刊数据库中使用选定的关键词进行文献检索,不限制出版日期。通过阅览题目和摘要,选择相关文章。专家意见:下眼睑和中脸应该被看作是一个连续体。目前,脂肪保存方法是下睑成形术的主流,以防止术后眼睛骨骼化。脂肪转位,通过带蒂脂肪皮瓣或游离脂肪移植,用于消除畸形和眼睑-脸颊交界处的撕裂,是美容下眼睑手术的主要目的。下睑成形术也可以与辅助手术相结合,以解决特定个体的花斑和中脸下垂。关键词:低blepharoplastylower eyelidtear troughtransconjunctival blepharoplastytransconjunctival blepharoplastyorbital脂肪的文章强调了下眼睑和中部的复合形态老化通常被指定为双凸性畸形。下睑成形术的概念已经从单纯的减容手术转变为脂肪复位、保守性皮肤切除和眼睑-脸颊交界处的融合。解除眼轮匝肌保留韧带是下睑成形术中至关重要的一步,特别是对于有眶下凹陷的患者。带蒂脂肪瓣转置术虽然能有效消除眶下凹陷,但也有一定的缺点。近年来的研究表明,下睑成形术中脂肪再分配的目的可以通过脂肪碎移植技术安全地实现。大多数,如果不是全部,下睑成形术最好辅以预防性眦锚定技术,以防止下睑错位。眼轮匝肌下脂肪提升是下眼睑脂肪复位的替代方法,特别是对于负矢量或颧隆起发育不全的患者。利益声明jd Clark是Horizon therapeutics的专业演讲者。除了披露的内容外,作者与任何组织或实体没有其他相关关系或财务参与,这些组织或实体与稿件中讨论的主题或材料有经济利益或经济冲突。审稿人披露本文的每位审稿人没有相关的财务或其他关系需要披露。本文未获得资助。
{"title":"Lower blepharoplasty; advanced techniques and adjunctive procedures","authors":"Nasser Karimi, Parya Abdolalizadeh, Hossein Ghahvehchian, Mansooreh Jamshidian Tehrani, Christopher J Compton, Jeremy D Clark, Nicole L West, Mohsen Bahmani Kashkouli","doi":"10.1080/17469899.2023.2281442","DOIUrl":"https://doi.org/10.1080/17469899.2023.2281442","url":null,"abstract":"ABSTRACTIntroduction There are two main techniques of lower blepharoplasty: transcutaneous and transconjunctival approaches. Most patients seeking lower eyelid rejuvenation have concomitant involutional changes in the lower eyelid and midface, which would better be addressed concurrently with the lower blepharoplasty procedure to yield better aesthetic and functional outcomes.Areas covered This study aims to review common aging-related changes in the lower eyelid as well as important preoperative considerations, surgical techniques, and various modifications of lower blepharoplasty. A literature search was performed in the PubMed database of English-language journals without restriction on the publication date using selected keywords. The relevant articles were selected by reviewing the titles and abstracts.Expert opinion The lower eyelid and midface should be perceived as a continuum. Currently the fat preservation approach is the mainstream in lower blepharoplasty to prevent postoperative skeletonization of the eye. Fat transposition, via either pedicled fat flaps or free fat grafts, is used to efface tear trough deformity and the eyelid-cheek junction as a primary aim inaesthetic lower eyelid surgeries. Lower blepharoplasty can also be combined with adjuvant procedures to address festoon and droopy midface in selected individuals.KEYWORDS: Lower blepharoplastylower eyelidtear troughtransconjunctival blepharoplastytransconjunctival blepharoplastyorbital fat Article highlights The composite morphology of lower eyelid and mid-face aging is commonly designated as the double convexity deformity.The concept of lower blepharoplasty has shifted from a pure subtractive surgery to fat reposition, conservative skin excision and blending of the eyelid-cheek junction.Releasing the orbicularis retaining ligament is a crucial step in lower blepharoplasty, specifically for patients with an untoward infraorbital hollow.Although pedicled fat flap transposition can effectively efface the infraorbital hollow, this technique has some downsides.Recently it has been demonstrated that the aims of fat redistribution in lower blepharoplasty can be safely achievable by the minced fat graft technique.Most, if not all, cases of lower blepharoplasty would better be complemented with prophylactic canthal anchoring techniques to prevent lower eyelid malposition.Suborbicularis oculi fat elevation is an alternative to lower eyelid fat repositioning, particularly for subjects with negative vectors or hypoplastic malar prominences.Declaration of interestsJD Clark is a professional speaker for Horizon therapeutics. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.Reviewer disclosuresPeer reviewers on this manuscript have no relevant financial or other relationships to disclose.Additio","PeriodicalId":39989,"journal":{"name":"Expert Review of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135037416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current challenges facing the clinical treatment for HTLV-1 ocular manifestations HTLV-1眼部表现临床治疗面临的挑战
Pub Date : 2023-11-09 DOI: 10.1080/17469899.2023.2281446
Koju Kamoi
ABSTRACTIntroduction Human T-lymphotropic virus type 1 (HTLV-1) is a lifelong persistent retrovirus associated with numerous systemic and ocular diseases, presenting significant clinical challenges.Areas covered A detailed overview of HTLV-1 associated ocular diseases is provided, along with the highlighting of recent findings challenging traditional views on transmission routes and the role of proviral load in HTLV-1 disease onset. The focus is on pathogenesis, clinical presentation, diagnostic approaches, current therapeutic strategies, recent advancements, and potential future directions in treatment.Expert opinion Recent discoveries emphasize the crucial role of horizontal transmission in HTLV-1 associated diseases, highlighting the need for heightened global awareness and effective screening practices. It’s revealed that HTLV-1 uveitis onset can be accelerated patients with Graves’ disease, despite a low proviral load and short latency period. Understanding such interplay and the pathogenesis of HTLV-1-associated ocular diseases is important in developing effective treatment strategies. Given the complexities of HTLV-1 ocular diseases, interdisciplinary collaboration is of the essence.KEYWORDS: Human T-lymphotropic virus type 1HTLV-1Horizontal transmissionHTLV-1 uveitisGraves’ diseaseKeratoconjunctivitis SiccaScleritisOptic neuritisAdult T-cell leukemia/lymphomaATLL-related ocular manifestationsOpportunistic infectionsHematopoietic stem cell transplantationDisclaimerAs a service to authors and researchers we are providing this version of an accepted manuscript (AM). Copyediting, typesetting, and review of the resulting proofs will be undertaken on this manuscript before final publication of the Version of Record (VoR). During production and pre-press, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal relate to these versions also. Article highlightsThe Human T-Cell Leukemia Virus-1 (HTLV-1) is associated with a wide range of ocular conditions, including HTLV-1 uveitis, keratoconjunctivitis sicca, interstitial keratitis, optic neuritis, overlap syndrome, and Adult T-cell leukemia/lymphoma (ATLL)-related ocular conditions. Each condition presents unique clinical challenges that necessitate an in-depth understanding and tailored treatment strategies for effective management.Therapeutic strategies for ocular inflammatory diseases related to HTLV-1, including HTLV-1 uveitis, currently focus on suppressing inflammation and controlling symptoms, largely through the use of steroids. This reliance on steroids punctuates the crucial need for new, targeted, and less invasive treatments. While potential solutions such as targeted drugs and biologics offer promising advances, it’s necessary to conduct further research to confirm their effectiveness, assess safety, and validate their use.The growing recognition of horizontal transmission as a significant route for HTLV-1-associated disease could d
甲巯咪唑治疗Graves病后HU的发展。(A)眼球突出伴格雷夫斯病。(B)右眼可见玻璃体混浊。(C)荧光素血管造影诊断视网膜血管炎。(图片经Kamoi et al., Lancet, 2022 [Citation26]许可转载)。显示完整尺寸图3(A)对HTLV-1相关疾病发展的传统认识。长潜伏期后的高原病毒载量被认为是ATLL、HAM/TSP和HU发病的关键因素。”(B)我们最近的发现。尽管原病毒载量低且潜伏期短,但在格雷夫斯病发病和随后的甲巯咪唑治疗后,年轻HTLV-1携带者可发生严重的HU。这表明在这些条件下,HU的发展速度加快。图4。眼部浸润的描述。图示白血病细胞浸润到眼睛的各个区域,突出了它们对眼部结构和视力的影响。显示完整尺寸图5结节样ATLL细胞多发性眼浸润(KAMOI)征象的临床图片。在角膜缘周围的球结膜和泪点周围的眼睑结膜(A)以及视网膜(B)可以观察到KAMOI标志(白色箭头标记)。浸润玻璃体的ATLL细胞倾向于聚集成多个簇(C)。(图片由KAMOI等人,角膜2016 [Citation92]许可复制;Kamoi等人,病毒。2022 [Citation18])。本文由JSPS KAKENHI资助(批准号:JSPS KAKENHI)。JP 20K09824),日本厚生劳动省罕见和难治性疾病资助项目(资助号:22FC0201),以及日本医学研究与开发机构(AMED)资助的新发和再发传染病研究计划(资助号:22FC0201)。23 fk0108671h0001 23 fk0108672h0001)。
{"title":"Current challenges facing the clinical treatment for HTLV-1 ocular manifestations","authors":"Koju Kamoi","doi":"10.1080/17469899.2023.2281446","DOIUrl":"https://doi.org/10.1080/17469899.2023.2281446","url":null,"abstract":"ABSTRACTIntroduction Human T-lymphotropic virus type 1 (HTLV-1) is a lifelong persistent retrovirus associated with numerous systemic and ocular diseases, presenting significant clinical challenges.Areas covered A detailed overview of HTLV-1 associated ocular diseases is provided, along with the highlighting of recent findings challenging traditional views on transmission routes and the role of proviral load in HTLV-1 disease onset. The focus is on pathogenesis, clinical presentation, diagnostic approaches, current therapeutic strategies, recent advancements, and potential future directions in treatment.Expert opinion Recent discoveries emphasize the crucial role of horizontal transmission in HTLV-1 associated diseases, highlighting the need for heightened global awareness and effective screening practices. It’s revealed that HTLV-1 uveitis onset can be accelerated patients with Graves’ disease, despite a low proviral load and short latency period. Understanding such interplay and the pathogenesis of HTLV-1-associated ocular diseases is important in developing effective treatment strategies. Given the complexities of HTLV-1 ocular diseases, interdisciplinary collaboration is of the essence.KEYWORDS: Human T-lymphotropic virus type 1HTLV-1Horizontal transmissionHTLV-1 uveitisGraves’ diseaseKeratoconjunctivitis SiccaScleritisOptic neuritisAdult T-cell leukemia/lymphomaATLL-related ocular manifestationsOpportunistic infectionsHematopoietic stem cell transplantationDisclaimerAs a service to authors and researchers we are providing this version of an accepted manuscript (AM). Copyediting, typesetting, and review of the resulting proofs will be undertaken on this manuscript before final publication of the Version of Record (VoR). During production and pre-press, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal relate to these versions also. Article highlightsThe Human T-Cell Leukemia Virus-1 (HTLV-1) is associated with a wide range of ocular conditions, including HTLV-1 uveitis, keratoconjunctivitis sicca, interstitial keratitis, optic neuritis, overlap syndrome, and Adult T-cell leukemia/lymphoma (ATLL)-related ocular conditions. Each condition presents unique clinical challenges that necessitate an in-depth understanding and tailored treatment strategies for effective management.Therapeutic strategies for ocular inflammatory diseases related to HTLV-1, including HTLV-1 uveitis, currently focus on suppressing inflammation and controlling symptoms, largely through the use of steroids. This reliance on steroids punctuates the crucial need for new, targeted, and less invasive treatments. While potential solutions such as targeted drugs and biologics offer promising advances, it’s necessary to conduct further research to confirm their effectiveness, assess safety, and validate their use.The growing recognition of horizontal transmission as a significant route for HTLV-1-associated disease could d","PeriodicalId":39989,"journal":{"name":"Expert Review of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135241102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of genetic testing for microphthalmia, anophthalmia and coloboma: experiences from a translational approach 基因检测对小眼、眼无和结肠瘤的影响:来自翻译方法的经验
Pub Date : 2023-11-08 DOI: 10.1080/17469899.2023.2281441
Richard Holt
{"title":"The impact of genetic testing for microphthalmia, anophthalmia and coloboma: experiences from a translational approach","authors":"Richard Holt","doi":"10.1080/17469899.2023.2281441","DOIUrl":"https://doi.org/10.1080/17469899.2023.2281441","url":null,"abstract":"","PeriodicalId":39989,"journal":{"name":"Expert Review of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135342138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving access to eye care in low and middle-income countries – challenges, opportunities, and the way forward 改善中低收入国家眼科医疗服务的可及性--挑战、机遇和前进方向
IF 0.7 Pub Date : 2023-11-02 DOI: 10.1080/17469899.2023.2281448
Srinivas Marmamula, V. K. Yelagondula, Rajashekar Varada, R. Khanna
ABSTRACT Introduction Vision loss is a public health challenge adversely affecting over a billion people worldwide. Low and middle income countries (LMICs) have a disproportionately higher prevalence of vision loss compared to high-income countries. Over 80% of vision loss can be addressed with either spectacles or cataract surgery. Both of these interventions are low cost and cost effective. Despite this, several barriers prevent individuals from accessing eye care. Areas covered This paper covers various elements of access (approachability, acceptability, affordability, availability and appropriateness) and presents barriers that prevent access to eye care services in LMICs. Disease-specific barriers and various models and strategies that address the accessibility challenges are presented with a special reference to the use of technology to improve access. Expert opinion Strategies such as providing free eye care, lowering direct and indirect costs, improve access to cataract surgery. While access-related challenges related to cataract surgery are well studied, there is inadequate information on access to refraction services for refractive errors and other conditions. Future research can focus on addressing this information gap. This can then help develop strategies to address the burden of uncorrected refractive errors and other causes of vision loss and contribute towards achieving universal eye health coverage. Search strategy used A literature search was carried out to identify the relevant articles reporting barriers to seeking eye care in the Medline, CINHAL and PsycINFO databases between 20 and 27 May 2023. From this search, the relevant articles were shortlisted for data extraction.
ABSTRACT 引言 视力丧失是一项公共卫生挑战,对全球十多亿人造成了不利影响。与高收入国家相比,中低收入国家(LMICs)的视力丧失率高得不成比例。超过 80% 的视力损失可以通过眼镜或白内障手术来解决。这两种干预措施的成本都很低,而且具有成本效益。尽管如此,仍有一些障碍阻碍人们获得眼科保健服务。本文涉及获得眼科保健服务的各种因素(可接近性、可接受性、可负担性、可获得性和适当性),并介绍了阻碍低收入和中等收入国家获得眼科保健服务的障碍。本文还介绍了针对特定疾病的障碍以及应对可及性挑战的各种模式和策略,并特别提到了利用技术改善可及性的问题。专家意见 提供免费眼科护理、降低直接和间接成本等战略可改善白内障手术的可及性。虽然与白内障手术相关的可及性挑战已得到充分研究,但有关屈光不正和其他情况下的屈光服务可及性的信息却不足。未来的研究可以重点解决这一信息缺口。这将有助于制定战略,解决未矫正屈光不正和其他视力丧失原因造成的负担,并为实现眼健康全民覆盖做出贡献。使用的检索策略 在 2023 年 5 月 20 日至 27 日期间,我们在 Medline、CINHAL 和 PsycINFO 数据库中进行了文献检索,以确定报道寻求眼科保健障碍的相关文章。通过检索,筛选出相关文章进行数据提取。
{"title":"Improving access to eye care in low and middle-income countries – challenges, opportunities, and the way forward","authors":"Srinivas Marmamula, V. K. Yelagondula, Rajashekar Varada, R. Khanna","doi":"10.1080/17469899.2023.2281448","DOIUrl":"https://doi.org/10.1080/17469899.2023.2281448","url":null,"abstract":"ABSTRACT Introduction Vision loss is a public health challenge adversely affecting over a billion people worldwide. Low and middle income countries (LMICs) have a disproportionately higher prevalence of vision loss compared to high-income countries. Over 80% of vision loss can be addressed with either spectacles or cataract surgery. Both of these interventions are low cost and cost effective. Despite this, several barriers prevent individuals from accessing eye care. Areas covered This paper covers various elements of access (approachability, acceptability, affordability, availability and appropriateness) and presents barriers that prevent access to eye care services in LMICs. Disease-specific barriers and various models and strategies that address the accessibility challenges are presented with a special reference to the use of technology to improve access. Expert opinion Strategies such as providing free eye care, lowering direct and indirect costs, improve access to cataract surgery. While access-related challenges related to cataract surgery are well studied, there is inadequate information on access to refraction services for refractive errors and other conditions. Future research can focus on addressing this information gap. This can then help develop strategies to address the burden of uncorrected refractive errors and other causes of vision loss and contribute towards achieving universal eye health coverage. Search strategy used A literature search was carried out to identify the relevant articles reporting barriers to seeking eye care in the Medline, CINHAL and PsycINFO databases between 20 and 27 May 2023. From this search, the relevant articles were shortlisted for data extraction.","PeriodicalId":39989,"journal":{"name":"Expert Review of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139290630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical management of macular holes: techniques, outcomes, and treatment of special cases 黄斑孔的手术治疗:技术、效果和特殊病例的治疗
IF 0.7 Pub Date : 2023-11-02 DOI: 10.1080/17469899.2023.2281447
Alexis S. Kassotis, Meera Ramakrishnan, T. Tezel
ABSTRACT Introduction Full-thickness macular hole is a visually significant condition with a very high surgical anatomical closure rate. Areas covered A literature review was performed focusing on surgical techniques for macular holes. What is known about the underlying anatomy and pathophysiology of macular hole formation is applied to surgical techniques that address the mechanisms for hole closure. Expert opinion While anatomic and functional success can be achieved at high rates, much is yet to be learned about the molecular and microstructural changes resulting from surgical manipulation. These insights will help guide novel techniques for complex cases which still suffer from suboptimal surgical outcomes.
ABSTRACT 引言 全厚黄斑孔是一种视觉上的重大疾病,手术解剖闭合率非常高。涉及领域 针对黄斑孔的手术技术进行了文献综述。将对黄斑孔形成的基本解剖学和病理生理学的了解应用于解决黄斑孔闭合机制的手术技术。专家意见 虽然解剖学和功能上的成功率很高,但对于手术操作导致的分子和微观结构变化,我们还有很多东西需要了解。这些见解将有助于指导新技术用于复杂病例,因为这些病例的手术效果仍不理想。
{"title":"Surgical management of macular holes: techniques, outcomes, and treatment of special cases","authors":"Alexis S. Kassotis, Meera Ramakrishnan, T. Tezel","doi":"10.1080/17469899.2023.2281447","DOIUrl":"https://doi.org/10.1080/17469899.2023.2281447","url":null,"abstract":"ABSTRACT Introduction Full-thickness macular hole is a visually significant condition with a very high surgical anatomical closure rate. Areas covered A literature review was performed focusing on surgical techniques for macular holes. What is known about the underlying anatomy and pathophysiology of macular hole formation is applied to surgical techniques that address the mechanisms for hole closure. Expert opinion While anatomic and functional success can be achieved at high rates, much is yet to be learned about the molecular and microstructural changes resulting from surgical manipulation. These insights will help guide novel techniques for complex cases which still suffer from suboptimal surgical outcomes.","PeriodicalId":39989,"journal":{"name":"Expert Review of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139290200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Expert Review of Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1